Table 1.
Clinical baseline characteristics
| Characteristics | Total (n = 732) | Group A (n = 628) | Group B (n = 104) | P |
|---|---|---|---|---|
| Age, mean ± SD | 66.17 ± 13.19 | 65.81 ± 13.14 | 68.34 ± 13.34 | 0.070 |
| < 50 | 78 (10.7) | 69 (11.0) | 9 (8.7) | 0.697 |
| 50–70 | 368 (50.3) | 322 (51.3) | 46 (44.2) | 0.561 |
| > 70 | 286 (39.0) | 237 (37.7) | 49 (47.1) | 0.661 |
| Female/Male [n (%)]X | 253/479 (34.6/65.4) | 211/417 (33.6/66.4) | 42/62 (40.4/59.6) | 0.178 |
| HBP, no/yes [n (%)] | 218/514 (29.8/70.2) | 190/438 (30.3/69.7) | 28/76 (26.9/73.1) | 0.491 |
| DM, no/yes [n (%)]H | 487/245 (66.5/33.5) | 424/204 (67.5/32.5) | 63/41 (60.6/39.4) | 0.165 |
| Hlip, no/yes [n (%)]H | 584/148 (79.8/20.2) | 496/132 (79.0/21.0) | 88/16 (84.6/15.4) | 0.185 |
| AF, no/yes [n (%)]H | 604/128 (82.5/17.5) | 541/ 87 (86.1/13.9) | 63/41 (60.6/39.4) | < 0.001 |
| SBP (mmHg) | 150.35 ± 23.26 | 150.54 ± 23.45 | 149.20 ± 22.14 | 0.586 |
| DBP (mmHg) | 84.71 ± 13.49 | 84.83 ± 13.73 | 83.98 ± 12.00 | 0.550 |
| NIHSS | 7.05 ± 6.27 | 6.50 ± 6.10 | 10.39 ± 6.25 | < 0.001 |
| Hypoproteinemia, no/yes [n (%)]H | 638/94 (87.2/12.8) | 550/78 (87.6/12.4) | 88/16(84.6/15.4) | 0.403 |
| Glucose (mmol/L) | 7.33 ± 3.63 | 7.19 ± 3.57 | 8.16 ± 3.87 | 0.011 |
| TC (mmol/L) | 4.36 ± 1.05 | 4.39 ± 1.04 | 4.15 ± 1.08 | 0.035 |
| < 3.10 | 77 (10.5) | 58 (9.3) | 19 (18.3) | 0.857 |
| 3.10–5.70 | 578 (79.0) | 507 (80.7) | 71 (68.2) | 0.047 |
| > 5.70 | 77 (10.5) | 63 (10.0) | 14 (13.5) | 0.038 |
| TG (mmol/L) | 1.41 ± 0.87 | 1.44 ± 0.90 | 1.24 ± 0.70 | 0.030 |
| < 0.57 | 47 (6.4) | 40 (6.4) | 7 (6.7) | 0.999 |
| 0.57–1.7 | 514 (70.2) | 435 (69.2) | 79 (76.0) | 0.044 |
| > 1.7 | 171 (23.4) | 153 (24.4) | 18 (17.3) | 0.417 |
| HDL-C (mmol/L) | 1.16 ± 0.33 | 1.15 ± 0.33 | 1.21 ± 0.32 | 0.074 |
| < 0.83H | 102 (13.9) | 92 (14.6) | 10 (9.6) | 0.192 |
| 0.83–1.96H | 614 (83.9) | 523 (83.3) | 91 (87.5) | 0.184 |
| > 1.96H | 16 (2.2) | 13 (2.1) | 3 (2.9) | 0.106 |
| LDL-C (mmol/L) | 2.83 ± 0.94 | 2.86 ± 0.92 | 2.67 ± 1.01 | 0.056 |
| < 2.07 | 152 (20.8) | 124 (19.7) | 28 (26.9) | 0.001 |
| 2.07–3.1 | 330 (45.0) | 285 (45.4) | 45 (43.3) | 0.443 |
| > 3.1 | 250 (34.2) | 219 (34.9) | 31 (29.8) | 0.761 |
(X). P values were calculated by one-way ANOVA, Pearson’s Chi-square test; (H). P values were calculated by the Kruskal-Wallis H (H) test; HT Hemorrhagic transformation postacute cerebral infarction; HBP: History of hypertension; DM: Diabetes mellitus; Hlip Hyperlipidemia; SBP Systolic pressure; DBP Diastolic pressure; NIHSS National Institutes of Health Stroke Scale; TC Total cholesterol; TG Triglyceride; HDL-C High-density lipoprotein cholesterol; LDL-C Low-density lipoprotein cholesterol